SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-16-147194
Filing Date
2016-09-28
Accepted
2016-09-28 16:57:14
Documents
82
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a16-17622_110k.htm 10-K 1379303
2 EX-21.1 a16-17622_1ex21d1.htm EX-21.1 3552
3 EX-23.1 a16-17622_1ex23d1.htm EX-23.1 4316
4 EX-31.1 a16-17622_1ex31d1.htm EX-31.1 13031
5 EX-31.2 a16-17622_1ex31d2.htm EX-31.2 13130
6 EX-32.1 a16-17622_1ex32d1.htm EX-32.1 6181
7 EX-32.2 a16-17622_1ex32d2.htm EX-32.2 6205
  Complete submission text file 0001104659-16-147194.txt   6549398

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ctrv-20160630.xml EX-101.INS 1170920
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20160630.xsd EX-101.SCH 74739
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20160630_cal.xml EX-101.CAL 49754
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20160630_def.xml EX-101.DEF 294394
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20160630_lab.xml EX-101.LAB 599166
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20160630_pre.xml EX-101.PRE 460526
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-36856 | Film No.: 161907542
SIC: 2834 Pharmaceutical Preparations